A multicenter Phase II study of mFOLFOX6 plus nivolumab for gastric cancer with severe peritoneal metastases: WJOG16322G
一项针对伴有严重腹膜转移的胃癌患者的多中心 II 期研究,评估 mFOLFOX6 联合纳武利尤单抗的疗效:WJOG16322G
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2514935
Wakabayashi, Munehiro; Masuishi, Toshiki; Ogata, Takatsugu; Hanamura, Fumiyasu; Furuta, Mitsuhiro; Yamamoto, Yoshiyuki; Kawakami, Kentaro; Hirano, Hidekazu; Kito, Yosuke; Izawa, Naoki; Takahashi, Naoki; Matsumoto, Toshihiko; Kawakami, Hisato; Ando, Takayuki; Minashi, Keiko; Kudo, Chiho; Yoshimura, Kenichi; Muro, Kei